Clinical Trials · NCT03708926
Effect of Abaloparatide on Lumbar Disc Degeneration
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Johns Hopkins University
- Enrollment
- 0
- Start date
- Mar 2021
- Locations
- 1 site, United States
- Primary endpoint
- Percentage of participants with improvement in symptomatic or radiographic symptoms as indicated by composite score aggregated from the Oswestry Disability Index (ODI) and Pfirrmann grading system